Health Minister Dr Aaron Motsoaledi reveals the ongoing challenges of medicine stock disruptions in South Africa, detailing ...

Objectives Challenges remain in ensuring universal access to affordable essential medicines. We previously estimated the expected generic prices based on cost of production for medicines in solid oral ...

About a decade ago, a group of competitive CrossFitters in Charleston, South Carolina, went looking for ways to improve their athletic performance without taking steroids. At the time, members of the ...

The approval of FILKRI marks the sixth product in Accord BioPharma's growing portfolio of FDA-approved biosimilars, following the company's acquisition last year of UDENYCA ® (pegfilgrastim-cbqv), a ...

Overview: Filgrastim is used to help prevent infection in people who have low levels of white blood cells (neutropenia). It may also be used before a stem cell transplant to increase the amount of ...

The injection is indicated to improve survival rates in individuals who have been acutely exposed to myelosuppressive levels of radiation. Credit: Me dia/Shutterstock.com. Lupin has received US Food ...

Introduction This research paper presents a study protocol for an exploratory clinical trial evaluating the safety and potential efficacy of autologous peripheral blood mononuclear cell (PBMNC)-loaded ...

The dynamic development of oncology poses new challenges to health care practitioners (HCPs), related to the introduction of modern targeted therapies, immunotherapies, or new chemotherapy regimens.

G-CSF is a type of protein called a growth factor. It is used to increase the number of white blood cells in the blood. It is best to read this information with our general information about the type ...

With the rapid decline in average sales price of reference pegfilgrastim products due to biosimilar competition, health care institutions and payers may grapple with coverage of Neulasta Onpro. With a ...

BOSTON--(BUSINESS WIRE)--Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology announced today that a permanent J-code, J1449, has been ...